Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katalyst Ventures is a private, active multi-stage venture capital firm focused on Applied AI, with investment activity spanning digital health, autonomous logistics, and enterprise SaaS. In healthcare, the firm backs companies that use machine learning and data-driven software to improve clinical operations, patient care, medical marketing, medication management, and health data workflows. The business is an investor rather than a therapeutic drug developer, so it does not appear to run an internal biopharma pipeline or advance proprietary clinical-stage assets. Its public materials highlight portfolio companies such as Arine, DocMatter, Zipline, and Carta Healthcare, reflecting an emphasis on AI-enabled healthcare and operational technology. For a biotech analyst, Katalyst Ventures is best understood as a healthcare-adjacent venture investor with meaningful exposure to digital health rather than a biotech, pharma, CRO, or therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katalyst Ventures.